Barrie Ashby

Affiliations: 
Temple University, Philadelphia, PA, United States 
Area:
Pharmacology, Neuroscience Biology
Google:
"Barrie Ashby"
Mean distance: 17811
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nagy B, Jin J, Ashby B, et al. (2011) Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. Journal of Thrombosis and Haemostasis : Jth. 9: 810-9
Mao Y, Zhang L, Jin J, et al. (2010) Mutational analysis of residues important for ligand interaction with the human P2Y(12) receptor. European Journal of Pharmacology. 644: 10-6
Bilson HA, Mitchell DL, Ashby B. (2004) Human prostaglandin EP3 receptor isoforms show different agonist-induced internalization patterns. Febs Letters. 572: 271-5
Ozdener F, Dangelmaier C, Ashby B, et al. (2002) Activation of phospholipase Cgamma2 by tyrosine phosphorylation. Molecular Pharmacology. 62: 672-9
Sakolsky DJ, Ashby B. (2001) Patterns of cyclic AMP formation by coexpressed D1 and D2L dopamine receptors in HEK 293 cells. Receptors & Channels. 7: 479-89
Desai S, Ashby B. (2001) Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor. Febs Letters. 501: 156-60
Sakolsky DJ, Ashby B. (2000) Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells. Brain Research. Molecular Brain Research. 84: 158-61
Desai S, April H, Nwaneshiudu C, et al. (2000) Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Molecular Pharmacology. 58: 1279-86
Xin L, Geller EB, Bastepe M, et al. (2000) Suppression of fever and hyperalgesic responses to the EP3-receptor agonist GR 63799X by EP3-receptor antisense in rats Journal of Thermal Biology. 25: 77-79
Bastepe M, Ashby B. (1999) Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor. British Journal of Pharmacology. 126: 365-71
See more...